Study details
Enrolling now
The ZARRA Trial
Washington State University
NCT IDNCT05134857ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
205
Study length
about 4.6 years
Ages
18–65
Locations
1 site in WA
What this study is about
Researchers are testing whether zonisamide, a medication, can help reduce alcohol use in adults with an alcohol use disorder. The trial will last for 1697 days and involve approximately 205 participants who are randomly assigned to receive either zonisamide or a placebo.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take Zonisamide
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
zonisamide
Drug routes
oral (Oral Capsule)
Body systems
Psychiatry / Mental Health